241 related articles for article (PubMed ID: 21865116)
1. In vitro activity of itraconazole in combination with terbinafine against clinical strains of itraconazole-insensitive Sporothrix schenckii.
Zhang X; Huang H; Feng P; Zhang J; Zhong Y; Xue R; Xie Z; Li M; Xi L
Eur J Dermatol; 2011; 21(4):573-6. PubMed ID: 21865116
[TBL] [Abstract][Full Text] [Related]
2. Synergistic effects of terbinafine and itraconazole on clinical isolates of Fonsecaea monophora.
ZHANG JM; XI LY; ZHANG H; XIE Z; SUN JF; LI XQ; LU S
Eur J Dermatol; 2009; 19(5):451-5. PubMed ID: 19502155
[TBL] [Abstract][Full Text] [Related]
3. In vitro susceptibility of isolates of Sporothrix schenckii to amphotericin B, itraconazole, and terbinafine: comparison of yeast and mycelial forms.
Kohler LM; Soares BM; de Assis Santos D; Da Silva Barros ME; Hamdan JS
Can J Microbiol; 2006 Sep; 52(9):843-7. PubMed ID: 17110976
[TBL] [Abstract][Full Text] [Related]
4. Antifungal susceptibility profile in vitro of Sporothrix schenckii in two growth phases and by two methods: microdilution and E-test.
Gutierrez-Galhardo MC; Zancopé-Oliveira RM; Monzón A; Rodriguez-Tudela JL; Cuenca-Estrella M
Mycoses; 2010 May; 53(3):227-31. PubMed ID: 19389067
[TBL] [Abstract][Full Text] [Related]
5. [In vitro susceptibility of isolates of Sporothrix schenckii to terbinafine and itraconazole].
Meinerz AR; Nascente Pda S; Schuch LF; Cleff MB; Santin R; Brum Cda S; Nobre Mde O; Meireles MC; Mello JR
Rev Soc Bras Med Trop; 2007; 40(1):60-2. PubMed ID: 17486256
[TBL] [Abstract][Full Text] [Related]
6. Susceptibility of Sporothrix brasiliensis isolates to amphotericin B, azoles, and terbinafine.
Borba-Santos LP; Rodrigues AM; Gagini TB; Fernandes GF; Castro R; de Camargo ZP; Nucci M; Lopes-Bezerra LM; Ishida K; Rozental S
Med Mycol; 2015 Feb; 53(2):178-88. PubMed ID: 25394542
[TBL] [Abstract][Full Text] [Related]
7. In vitro susceptibilities of isolates of Sporothrix schenckii to itraconazole and terbinafine.
Kohler LM; Monteiro PC; Hahn RC; Hamdan JS
J Clin Microbiol; 2004 Sep; 42(9):4319-20. PubMed ID: 15365033
[TBL] [Abstract][Full Text] [Related]
8. Sporothrix schenckii complex in Iran: Molecular identification and antifungal susceptibility.
Mahmoudi S; Zaini F; Kordbacheh P; Safara M; Heidari M
Med Mycol; 2016 Aug; 54(6):593-9. PubMed ID: 26933207
[TBL] [Abstract][Full Text] [Related]
9. Antifungal activity of diphenyl diselenide alone and in combination with itraconazole against Sporothrix brasiliensis.
Poester VR; Mattei AS; Mendes JF; Klafke GB; Ramis IB; Sanchotene KO; Xavier MO
Med Mycol; 2019 Apr; 57(3):328-331. PubMed ID: 29924365
[TBL] [Abstract][Full Text] [Related]
10. Refractory sporotrichosis due to Sporothrix brasiliensis in humans appears to be unrelated to in vivo resistance.
Almeida-Paes R; Oliveira MME; Freitas DFS; Valle ACFD; Gutierrez-Galhardo MC; Zancopé-Oliveira RM
Med Mycol; 2017 Jul; 55(5):507-517. PubMed ID: 27771622
[TBL] [Abstract][Full Text] [Related]
11. In vitro evaluation of combination antifungal activity against Fusarium species isolated from ocular tissues of keratomycosis patients.
Li L; Wang Z; Li R; Luo S; Sun X
Am J Ophthalmol; 2008 Nov; 146(5):724-8. PubMed ID: 18707669
[TBL] [Abstract][Full Text] [Related]
12. In vitro interactions of antifungal agents against clinical isolates of Fusarium spp.
Córdoba S; Rodero L; Vivot W; Abrantes R; Davel G; Vitale RG
Int J Antimicrob Agents; 2008 Feb; 31(2):171-4. PubMed ID: 18054469
[TBL] [Abstract][Full Text] [Related]
13. Canine sporotrichosis: polyphasic taxonomy and antifungal susceptibility profiles of Sporothrix species in an endemic area in Brazil.
Boechat JS; Pereira SA; de Sá Machado AC; Viana PG; Almeida-Paes R; Zancopé-Oliveira RM; Gremião IDF; de Oliveira MME
Braz J Microbiol; 2021 Mar; 52(1):135-143. PubMed ID: 32617836
[TBL] [Abstract][Full Text] [Related]
14. Melanins Protect Sporothrix brasiliensis and Sporothrix schenckii from the Antifungal Effects of Terbinafine.
Almeida-Paes R; Figueiredo-Carvalho MH; Brito-Santos F; Almeida-Silva F; Oliveira MM; Zancopé-Oliveira RM
PLoS One; 2016; 11(3):e0152796. PubMed ID: 27031728
[TBL] [Abstract][Full Text] [Related]
15. Molecular Identification and Antifungal Susceptibility of Clinical Isolates of Sporothrix schenckii Complex in Medellin, Colombia.
Flórez-Muñoz SV; Alzate JF; Mesa-Arango AC
Mycopathologia; 2019 Feb; 184(1):53-63. PubMed ID: 30554299
[TBL] [Abstract][Full Text] [Related]
16. In vitro susceptibility of Sporothrix brasiliensis: Comparison of yeast and mycelial phases.
Sanchotene KO; Brandolt TM; Klafke GB; Poester VR; Xavier MO
Med Mycol; 2017 Nov; 55(8):869-876. PubMed ID: 28472490
[TBL] [Abstract][Full Text] [Related]
17. Sporothrix schenckii COMPLEX:SUSCEPTIBILITIES TO COMBINED ANTIFUNGAL AGENTS AND CHARACTERIZATION OF ENZYMATIC PROFILES.
Oliveira DC; de Loreto ÉS; Mario DA; Lopes PG; Neves LV; da Rocha MP; Santurio JM; Alves SH
Rev Inst Med Trop Sao Paulo; 2015; 57(4):289-94. PubMed ID: 26422151
[TBL] [Abstract][Full Text] [Related]
18. In vitro antifungal susceptibility of Sporothrix globosa isolates from Jilin Province, northeastern China: comparison of yeast and mycelial phases.
Song Y; Li S; Shi Y; Zhao L; Cui Y; Yao L; Zhen Y; Chen R; Cui Y
Braz J Microbiol; 2021 Mar; 52(1):81-90. PubMed ID: 32557246
[TBL] [Abstract][Full Text] [Related]
19. Influence of iron on growth and on susceptibility to itraconazole in Sporothrix spp.
da Silva Hellwig AH; Pagani DM; Rios IDS; Ribeiro AC; Zanette RA; Scroferneker ML
Med Mycol; 2021 Apr; 59(4):400-403. PubMed ID: 33305309
[TBL] [Abstract][Full Text] [Related]
20. Potential use of Nikkomycin Z as an anti- Sporothrix spp. drug.
Poester VR; Munhoz LS; Larwood D; Martinez M; Stevens DA; Xavier MO
Med Mycol; 2021 Apr; 59(4):345-349. PubMed ID: 32634218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
